Amgen Inc (AMGN) P/FCF 22.7 | Overview

Search global stocks & ETFs...Ctrl K

Learn Mode

Amgen IncAMGN

$361.33

-$0.79 (-0.218%)

at close

$362.86

$1.53 (0.424%)

pre market · 8:09 AM

3.67/5

General

Scores

Financials & KPIs

Dividends

Analyst

Insider

Updates

AMGN

Stock Profile

Market Cap

Industry

EPS (TTM)

P/E (TTM)

Div & Yield

FCF Payout Ratio

P/S (TTM)

P/B

Revenue Growth (TTM)

EPS CAGR (3Y)

Diluted Shares

Ex-Dividend

Next Earnings

Forward P/E

Payout Ratio

P/FCF (TTM)

FCF Yield

Earnings Yield

Revenue CAGR (3Y)

Recommended Metric

Score Card

Explore Scores Tab

3.67

Good

Amgen Inc has grown revenue at 9.07% over the past year, which suggests sales are increasing. Also, it has a free cash flow margin of 23.1%, which suggests the company is very profitable.

Valuation Score

Key Score

3.00

Average

Management

3.00

Average

Growth

4.00

Good

Profitability

1.00

Very Bad

Fin. Health

2.00

Bad

Dividends

4.00

Good

Analyst

3.00

Average

Financials

Explore Financial Tab ›

Revenue

Earnings

Free Cash Flow

Insider Transactions

Explore Insider Tab ›

Buy Transactions

Sell Transactions

Peers

Select stocks to compare

NTRANatera Inc

$276.27

+1.78%

REGNRegeneron Pharmaceuticals Inc

$624.72

+0.19%

950200.KQPsomagen Inc

ALNYAlnylam Pharmaceuticals Inc

$301.67

+0.21%

RVMDRevolution Medicines Inc

$187.51

+0.12%

GILDGilead Sciences, Inc

$125.97

-0.29%

950160.KQKolon Tissuegene Inc

₩93,000.00

-0.64%

VRTXVertex Pharmaceuticals Inc

$498.01

+0.26%

950220.KQNeoimmunetech Inc

₩0.00

null%

Price Targets & Ratings

View Analysis

1-year price targets, ending May 11, 2027

Current

$361.33

Baseline

High

$453.60

▲

25.54%

Avg

$366.97

▲

1.56%

Low

$202.00

▼

-44.10%

Analyst Ratings based on 44 Analysts

Strong Buy

14%

Buy

36%

Hold

43%

Sell

05%

Strong Sell

02%

About

Stock News

View All Updates